Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Amyloidosis
ADR ID BADD_A00175
ADR Hierarchy
10      Immune system disorders
10.02      Immune disorders NEC
10.02.05      Amyloidoses
10.02.05.001      Amyloidosis
Description A group of sporadic, familial and/or inherited, degenerative, and infectious disease processes, linked by the common theme of abnormal protein folding and deposition of AMYLOID. As the amyloid deposits enlarge they displace normal tissue structures, causing disruption of function. Various signs and symptoms depend on the location and size of the deposits. [MeSH]
MedDRA Code 10002022
MeSH ID D000686
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Amyloid disease | Amyloidosis | Amyloidosis NOS | Amyloidoses
ADR Related Proteins
Protein Name UniProt AC TTD Target ID
Not AvailableNot AvailableNot Available
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D00151Apixaban0.000276%
BADD_D00194Azacitidine0.000139%
BADD_D00284Bortezomib0.000695%
BADD_D00285Bosentan0.000117%
BADD_D00367Carfilzomib0.000208%
BADD_D00479Cladribine--
BADD_D00564Dabigatran etexilate0.000275%
BADD_D00732Droxidopa0.000339%
BADD_D01253Lenalidomide0.006193%
BADD_D01756Phentermine0.000386%
BADD_D01798Pomalidomide0.001510%
BADD_D02105Tacrolimus0.000555%
BADD_D02192Thalidomide0.000755%
BADD_D02321Ursodiol--
The 1th Page    1    Total 1 Pages